ImmuCell CorporationICCCNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+138.3%
5Y CAGR+23.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+138.3%/yr
vs +41.0%/yr prior
5Y CAGR
+23.5%/yr
Recent acceleration
Acceleration
+97.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.73M+343.9%
2024$1.07M+142.6%
2023$-2.50M-815.5%
2022$349990.00-87.0%
2021$2.70M+63.7%
2020$1.65M+15.1%
2019$1.43M+1518.9%
2018$88442.00-87.1%
2017$684529.00-60.3%
2016$1.72M-